Redhill Biopharma Ltd (STU:2RH0)
€ 0.431 0.029 (7.21%) Market Cap: 13.74 Mil Enterprise Value: 9.70 Mil PE Ratio: 0 PB Ratio: 4.59 GF Score: 50/100

Redhill Biopharma Ltd at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 11, 2021 / 01:35PM GMT
Release Date Price: €256
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good morning, everyone. My name is Balaji Prasad. I lead the Specialty Pharma coverage for Barclays. Thank you for dialing in to the day 3 of Barclays Global Healthcare Conference.

And on the specialty pharma track of the conference today, I'm pleased to introduce the CEO of RedHill, Dror Ben-Asher today with us. The format is going to be a 10 to 12 minute presentation from Dror and then similar duration around -- for a fireside Q&A.

With this, Dror, thank you for taking your time today, and I invite you to take over.

Dror Ben;Asher
RedHill Biopharma Ltd. - Co-Founder, Chairman & CEO

Thank you. Thank you, Balaji, and thank you Barclays team for having us with you here. What we're going to do is a quick overview presentation, and then we'll take it from there to answer some questions.

For those of you who are not familiar with Red Hill. We are an asset listed company. We've been around for about 10 years, relatively on company and we are a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot